These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8976875)

  • 1. Expression of cripto in human gall bladder lesions.
    Fujii K; Yasui W; Kuniyasu H; Itoh M; Hanada K; Kajiyama G; Tahara E
    J Pathol; 1996 Oct; 180(2):166-8. PubMed ID: 8976875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis.
    Mikami T; Yanagisawa N; Baba H; Koike M; Okayasu I
    Cancer; 1999 Jan; 85(2):318-25. PubMed ID: 10023698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors.
    Saeki T; Stromberg K; Qi CF; Gullick WJ; Tahara E; Normanno N; Ciardiello F; Kenney N; Johnson GR; Salomon DS
    Cancer Res; 1992 Jun; 52(12):3467-73. PubMed ID: 1596904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
    Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
    Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunohistochemical detection of cripto-1 in benign and malignant human bladder.
    Byrne RL; Autzen P; Birch P; Robinson MC; Gullick WJ; Neal DE; Hamdy FC
    J Pathol; 1998 May; 185(1):108-11. PubMed ID: 9713367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas.
    Hong SP; Lee EK; Park JY; Jeon TJ; Bang S; Park S; Chung JB; Lee WJ; Kim H; Song SY
    Oncol Rep; 2009 Jan; 21(1):19-24. PubMed ID: 19082438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
    Liu DC; Yang ZL
    Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
    Billo P; Marchegiani C; Capella C; Sessa F
    Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
    Kim YW; Park YK; Yoon TY; Lee SM
    Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More frequent beta-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages.
    Yanagisawa N; Mikami T; Saegusa M; Okayasu I
    Cancer Res; 2001 Jan; 61(1):19-22. PubMed ID: 11196159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study.
    Yamato T; Sasaki M; Watanabe Y; Nakanuma Y
    J Pathol; 1999 May; 188(1):30-7. PubMed ID: 10398137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.
    Gong YP; Yarrow PM; Carmalt HL; Kwun SY; Kennedy CW; Lin BP; Xing PX; Gillett DJ
    Eur J Surg Oncol; 2007 May; 33(4):438-43. PubMed ID: 17125961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bimodal expression of heparin-binding EGF-like growth factor in colonic neoplasms.
    Ito Y; Higashiyama S; Takeda T; Okada M; Matsuura N
    Anticancer Res; 2001; 21(2B):1391-4. PubMed ID: 11396220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of AgNORs in diagnosis of early malignant lesions of gall bladder.
    Misra V; Misra SP; Dwivedi M; Gupta SC
    Indian J Pathol Microbiol; 1995 Oct; 38(4):383-8. PubMed ID: 9726148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder.
    Li X; Hui AM; Shi YZ; Takayama T; Makuuchi M
    Hum Pathol; 2001 Aug; 32(8):771-7. PubMed ID: 11521218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo.
    Strizzi L; Bianco C; Raafat A; Abdallah W; Chang C; Raafat D; Hirota M; Hamada S; Sun Y; Normanno N; Callahan R; Hinck L; Salomon D
    J Cell Sci; 2005 Oct; 118(Pt 20):4633-43. PubMed ID: 16176936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CDC6 and GDF-9 and their clinicopathological significances in benign and malignant lesions of the gallbladder.
    Shu GS; Yang LP; Yang ZL; Jiang S
    Cancer Biomark; 2012; 11(2-3):107-14. PubMed ID: 23011157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.